Answers are grounded in this paper and cite their sources.
Chronic stroke walking impairment is associated with high healthcare resource utilization (HCRU) costs. InTandem™ is a neurorehabilitation system that autonomously delivers a rhythmic auditory stimulation (RAS)-based intervention for the at-home rehabilitation of walking impairment in adults in the chronic phase of stroke recovery. This study was conducted to estimate the budget impact of InTandem in comparison with currently available intervention strategies for improvement of gait/ambulation in individuals with chronic stroke walking impairment.
No takes yet. Share an insight, caveat, or question.
Smayda et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: